Literature DB >> 18951791

Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents.

Ashok Kumar1, Kumkum Srivastava, S Raja Kumar, S K Puri, Prem M S Chauhan.   

Abstract

The emergence and rapid spread of chloroquine resistant strains of Plasmodium falciparum has dramatically reduced the chemotherapeutic options. Towards this goal, a series of new class of hybrid 4-aminoquinoline triazines were synthesized and screened against CQ sensitive strain 3D7 of P. falciparum in an in vitro model. Compounds 65 and 69 exhibited more than 99% suppression on day 4 and on day 6 post treatment, compound 69 showed impressive 99.11% suppression against CQ resistant strain N-67 of P. yoelii in an in vivo assay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951791     DOI: 10.1016/j.bmcl.2008.10.049

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream?

Authors:  Drishti Agarwal; Rinkoo D Gupta; Satish K Awasthi
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Evaluation of xanthene-appended quinoline hybrids as potential leads against antimalarial drug targets.

Authors:  R Jesu Jaya Sudan; J Lesitha Jeeva Kumari; P Iniyavan; S Sarveswari; V Vijayakumar
Journal:  Mol Divers       Date:  2022-05-18       Impact factor: 2.943

3.  Quinoline: A versatile heterocyclic.

Authors:  Akranth Marella; Om Prakash Tanwar; Rikta Saha; Mohammad Rahmat Ali; Sandeep Srivastava; Mymoona Akhter; Mohammad Shaquiquzzaman; Mohammad Mumtaz Alam
Journal:  Saudi Pharm J       Date:  2012-03-29       Impact factor: 4.330

4.  Comparative biological study between quinazolinyl-triazinyl semicarbazide and thiosemicarbazide hybrid derivatives.

Authors:  Janki J Patel; Rahul P Modh; Manjoorahmed Asamdi; Kishor H Chikhalia
Journal:  Mol Divers       Date:  2020-06-28       Impact factor: 2.943

5.  Ciprofloxacin is an inhibitor of the Mcm2-7 replicative helicase.

Authors:  Nicholas Simon; Matthew L Bochman; Sandlin Seguin; Jeffrey L Brodsky; William L Seibel; Anthony Schwacha
Journal:  Biosci Rep       Date:  2013-10-07       Impact factor: 3.840

Review 6.  Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.

Authors:  Wan-Yin Fang; L Ravindar; K P Rakesh; H M Manukumar; C S Shantharam; Njud S Alharbi; Hua-Li Qin
Journal:  Eur J Med Chem       Date:  2019-04-10       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.